scholarly journals Roles and functions of a European Union Public Health Centre for Communicable Diseases and other threats to health

2002 ◽  
Vol 7 (5) ◽  
pp. 78-84 ◽  
Author(s):  
F Van Loock ◽  
N Gill ◽  
S Wallyn ◽  
A Nicoll ◽  
J C Desenclos ◽  
...  

An international consensus has been reached that a European Union (EU) Technical Coordination Structure (TCS) for communicable diseases is needed to improve Europe’s future response to international communicable disease threats within and beyond its boundaries. After the American events of September 11 2001 and the deliberate releases of anthrax, the EU created a Health Security Committee, adopted a civil protection decision, and established for 18 months a team to develop responses for deliberate releases of biological and chemical agents. These two initiatives, the network’s approach and health security work, must converge into a single stream addressing health protection for the people of Europe. They could be combined into a European Centre for Communicable Diseases that is planned to become active by 2005.

2004 ◽  
Vol 8 (19) ◽  
Author(s):  
Dalia Rokaite ◽  
N Kupreviciene

The Lithuanian Centre for Communicable Diseases Prevention and Control (CCDPC, Užkreciamuju ligu profilaktikos ir kontroles centras) in Vilnius was established in 1997 after the reorganisation of the State Immunisation Centre and the Department of Communicable Diseases at the State Public Health Centre


2001 ◽  
Vol 6 (3) ◽  
pp. 37-43 ◽  
Author(s):  
F van Loock ◽  
Mike Rowland ◽  
T Grein ◽  
A Moren

Within the widening European Union, large-scale movements of people, animals and food-products increasingly contribute to the potential for spread of communicable diseases. The EU was given a mandate for public health action only in 1992, under the Treaty of European Union ("Maastricht Treaty"), which was broadened in the 1997 with the Treaty of Amsterdam. While all EU countries have statutory requirements for notifying communicable diseases, national and regional communicable disease surveillance practices vary considerably (1). The Network Committee (NC) for the Epidemiological Surveillance and Control of Communicable Diseases in the EU was established in 1998 to harmonise these activities.


2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
N M Mahrouseh ◽  
D W Njuguna ◽  
O A Varga

Abstract Background There is an alerting increase in the population affected by type 2 diabetes mellitus (T2DM) in the European Union (EU) with significant socioeconomic burden. According to an estimation by the International Diabetes Federation, by 2030, the total number of diabetic patients will be 38 million in EU. The “screen and treat” strategies that predominantly applied in policies to prevent T2DM have not achieved significant success, as reported by a large systematic review and meta-analysis published in 2017. Although the member states of the EU have almost full responsibilities for actions in the field of health, the EU has to tackle non-communicable diseases by targeting health determinants and lifestyle mostly through non-binding policies. The goal of this work is to review the T2DM prevention policies in the EU and compare with tobacco policies, from a legal perspective. Methods Following the systematic search and screening of policies from EUR-lex, a content analysis was carried out by using MonQcle as publicly available legal text document analysis platform, by two coders. The search was limited for regulations, directives and white papers. Results Our data collection consisted of 19 documents including 10 regulations, 6 directives and 3 white papers with relevance to T2DM, covering the following topics: health infrastructure and services, informational policies, economic policies, environmental policies, command and control and social policies. The identified policies covered the time frame of 1972 to 2020. Diabetes was targeted as part of non-communicable diseases. None of the policies was legally binding addressing T2DM directly which is in sharp contrast to the tobacco control policies in the EU. Conclusions T2DM, in fact, is largely preventable. EU institutions should consider to reframe T2DM prevention strategies and consider applying a wide range of population-level legislative and innovative actions to prevent T2DM e.g. taxes on unhealthy food products. Key messages T2DM is a largely preventable disease, effective legal tools should be created and applied matching the scale of such public health problem. T2DM policies of the EU may be subject to change due to additional value of actions taken by the EU compared to that could have been achieved by member states alone.


2005 ◽  
Vol 10 (48) ◽  
Author(s):  
G Zagrebneviene ◽  
V Jasulaitiene ◽  
B Morkunas ◽  
S Tarbunas ◽  
J Ladygaite

On 7 October 2004, the Vilnius Public Health Centre reported five shigellosis cases in Vilnius, all typed as Shigellosis sonnei, to the National Centre for Communicable Diseases Prevention and Control. Preliminary patient data suggested that the infections were all acquired from unpasteurised milk curds bought from two markets in Vilnius.


Author(s):  
Sharifah Sekalala ◽  
John Harrington

This chapter examines the influence of human rights in the quest to control communicable diseases. Communicable diseases are emerging and spreading faster than ever before, with devastating consequences for the most vulnerable in a rapidly globalizing world. Human rights have come to frame infectious disease control, beginning in the early response to AIDS and expanding from the stigmatization of marginalized populations to include the provision of essential medicines. Human rights claims have correspondingly expanded, arising out of norms of non-discrimination, consent, and privacy and now including the right to health. As individual rights compete with state authority, the World Health Organization’s (WHO’s) International Health Regulations (2005) aim to guide states in a rights-based response to communicable disease. However, as seen in recent Ebola outbreaks, human rights have lost priority to health security as the dominant frame for health policy, and this securitization of communicable disease control may undermine the gains of human rights, risking the future of global health.


Author(s):  
Amir Su'udi ◽  
Harimat Hendarwan

Abstrak Pemerintah Kabupaten Tabalong Kalimantan Selatan menerapkan pelayanan kesehatan gratis di Puskesmas melalui program Jaminan Tabalong Sehat (JTS) sejak tahun 2008. Peserta JTS adalah seluruh penduduk Tabalong yang tidak memiliki asuransi atau jaminan kesehatan. Penelitian ini bertujuan mengetahui faktor-faktor yang berhubungan dengan pemanfaatan pelayanan kesehatan di puskesmas. Penelitian ini menggunakan desain cross sectional dan wawancara mendalam. Sampel uji sebanyak 253 rumah tangga sasaran program JTS, diambil dari 405 sampel rumah tangga yang dipilih secara sistematik, dari klaster 15 desa/kelurahan di tiga wilayah puskesmas terpilih. Hasil penelitian menunjukkan bahwa pemanfaatan pelayanan kesehatan gratis di puskesmas belum optimal. Sebanyak 52% rumah tangga pernah memanfaatkan pelayanan kesehatan puskesmas dalam setahun terakhir. Faktor yang berhubungan dengan pemanfaatan pelayanan kesehatan di puskesmas adalah pengetahuan, kemauan untuk membayar/WTP, adanya penyakit tertentu, waktu tempuh, kemudahan dan biaya transportasi. Rendahnya pemanfaatan pelayanan kesehatan di puskemas yang sudah digratiskan disebabkan karena kurang optimalnya kegiatan puskesmas, kurangnya sosialisasi ke masyarakat dan sasaran masyarakat yang disubsidi kurang tepat. Kata kunci: Pemanfaatan pelayanan kesehatan, Puskesmas, Subsidi, Tabalong Abstract Government of Tabalong District have been giving free health care subsidies at public health centre (PHC) through Tabalong Health Security (Jaminan Tabalong Sehat /JTS) program since 2008. Targetting of JTS program are all of Tabalong citizens that have not covered by health insurance or other health security programs. The objective of this research was to know the factors that related with utilization of health services at PHC in Tabalong District. Approach of this research were cross sectional design and deep interview. Sampels were 253 targetting household taken form 405 household that selected by systematic random from 15 villages cluster at three selected PHC areas. The result showed that utilization of free health services subsidies were not optimize yet. Just 52% of household utilized health services at PHC in the last year. The factors that related with health services utilization at PHC are knowledge, willingness to pay (WTP), diseases avalaibility, travelling time, easiness and cost of transportation. The low rates utilization of free health care were also caused by un-optimize of PHC’s activities, lack of promotion the JTS programs, not matching of subsidies targetting. Keywords: Health services utilization, public health centre, subsidy, Tabalong


Author(s):  
Sekalala Sharifah ◽  
Harrington John

This chapter examines the influence of human rights in the quest to control communicable diseases. Communicable diseases are emerging and spreading faster than ever before, with devastating consequences for the most vulnerable in a rapidly globalizing world. Human rights have come to frame infectious disease control, beginning in the early response to AIDS and expanding from the stigmatization of marginalized populations to include the provision of essential medicines. Human rights claims have correspondingly expanded, arising out of norms of non-discrimination, consent, and privacy and now including the right to health. As individual rights compete with state authority, the World Health Organization’s (WHO’s) International Health Regulations (2005) aim to guide states in a rights-based response to communicable disease. However, as seen in recent Ebola outbreaks, human rights have lost priority to health security as the dominant frame for health policy, and this securitization of communicable disease control may undermine the gains of human rights, risking the future of global health.


2019 ◽  
Vol 30 (4) ◽  
pp. 833-839 ◽  
Author(s):  
Désirée Vandenberghe ◽  
Johan Albrecht

Abstract Background Non-communicable diseases (NCDs) impose a significant and growing burden on the health care system and overall economy of developed (and developing) countries. Nevertheless, an up-to-date assessment of this cost for the European Union (EU) is missing from the literature. Such an analysis could however have an important impact by motivating policymakers and by informing effective public health policies. Methods Following the PRISMA protocol, we conduct a systematic review of electronic databases (PubMed/Medline, Embase, Web of Science Core Collection) and collect scientific articles that assess the direct (health care-related) and indirect (economic) costs of four major NCDs (cardiovascular disease, cancer, type-2 diabetes mellitus and chronic respiratory disease) in the EU, between 2008 and 2018. Data quality was assessed through the Newcastle–Ottawa Scale. Results We find 28 studies that match our criteria for further analysis. From our review, we conclude that the four major NCDs in the EU claim a significant share of the total health care budget (at least 25% of health spending) and they impose an important economic loss (almost 2% of gross domestic product). Conclusion The NCD burden forms a public health risk with a high financial impact; it puts significant pressure on current health care and economic systems, as shown by our analysis. We identify a further need for cost analyses of NCDs, in particular on the impact of comorbidities and other complications. Aside from cost estimations, future research should focus on assessing the mix of public health policies that will be most effective in tackling the NCD burden.


2020 ◽  
Vol 5 (10) ◽  
pp. e003276
Author(s):  
Matthew J Boyd ◽  
Nick Wilson ◽  
Cassidy Nelson

IntroductionThe COVID-19 pandemic powerfully demonstrates the consequences of biothreats. Countries will want to know how to better prepare for future events. The Global Health Security Index (GHSI) is a broad, independent assessment of 195 countries’ preparedness for biothreats that may aid this endeavour. However, to be useful, the GHSI’s external validity must be demonstrated. We aimed to validate the GHSI against a range of external metrics to assess how it could be utilised by countries.MethodsGlobal aggregate communicable disease outcomes were correlated with GHSI scores and linear regression models were examined to determine associations while controlling for a number of global macroindices. GHSI scores for countries previously exposed to severe acute respiratory syndrome (SARS), Middle East respiratory syndrome and Ebola and recipients of US Global Health Security Agenda (GHSA) investment were compared with matched control countries. Possible content omissions in light of the progressing COVID-19 pandemic were assessed.ResultsGHSI scores for countries had strong criterion validity against the Joint External Evaluation ReadyScore (rho=0.82, p<0.0001), and moderate external validity against deaths from communicable diseases (−0.56, p<0.0001). GHSI scores were associated with reduced deaths from communicable diseases (F(3, 172)=22.75, p<0.0001). The proportion of deaths from communicable diseases decreased 4.8% per 10-point rise in GHSI. Recipient countries of the GHSA (n=31) and SARS-affected countries (n=26), had GHSI scores 6.0 (p=0.0011) and 8.2 (p=0.0010) points higher than matched controls, respectively. Biosecurity and biosafety appear weak globally including in high-income countries, and health systems, particularly in Africa, are not prepared. Notably, the GHSI does not account for all factors important for health security.ConclusionThe GHSI shows promise as a valid tool to guide action on biosafety, biosecurity and systems preparedness. However, countries need to look beyond existing metrics to other factors moderating the impact of future pandemics and other biothreats. Consideration of anthropogenic and large catastrophic scenarios is also needed.


2000 ◽  
Vol 48 (1_suppl) ◽  
pp. 21-47
Author(s):  
John Markoff

In this chapter, John Markoff notes that although the European Union has a strong formal commitment to democratic values, for example in the tests it applies to new entrants, and although civic freedoms are strong throughout the EU, this body nevertheless poses a challenge to democratisation. This is because the development of democratic freedoms and political practices has, since the eighteenth century, been accompanied by the activities of social movements that have placed pressure ‘from below’ upon government bodies, making them accountable to the people. As more governmental power drifts upwards, above the level of the national state, the capacity of social movements to exercise influence decreases. Paradoxically, while the EU supports democracy within its member states, it remains relatively free of effective democratic control itself. During the nineteenth century, social movements reoriented themselves from local power structures to national states but they have been less effective in reorienting themselves yet again to the suprastate level.


Sign in / Sign up

Export Citation Format

Share Document